“…The DASH has been the most popular PROM for studying Dupuytren’s disease treatment (Ball et al, 2013). However, its validity has been questioned in a study with contemporary design (Forget et al, 2014), as well as in previous studies, which have more limitations (Degreef et al, 2009, Engstrand et al, 2009, Jerosch-Herold et al, 2011, Packham, 2011, Zyluk and Jagielski, 2007). Our study raises further questions regarding its suitability for use in Dupuytren’s disease, in terms of poor interpretability, an aspect of its behaviour that has not been studied previously for Dupuytren’s disease.…”